Recent Research Analysts’ Ratings Updates for Corbus Pharmaceuticals (CRBP)
Corbus Pharmaceuticals (NASDAQ: CRBP) has recently received a number of price target changes and ratings updates: 3/12/2025 – Corbus Pharmaceuticals had its “outperform” rating reaffirmed by analysts at Wedbush. They now have a $51.00 price target on the stock. 3/12/2025 – Corbus Pharmaceuticals had its “buy” rating reaffirmed by analysts at HC Wainwright. They now […]
13 Mar 14:24 · The Cerbat Gem